top of page
Contact Us
Contact Us

More case studies

Ensuring batch-consistent, compliant comparator supply across NA, EU, and APAC - on time and uninterrupted.

Effective Sourcing of Semaglutide for a Global Phase III Clinical Trial

From supply shortfall to on-time first-patient-first-visit across Europe, delivered in three days.

CSI's 72-hour Abraxane Rescue Mission

Adaptive, multi-product supply across 22 countries and 80 sites, kept on time, in budget and compliant.

CSI’s Expert Delivery of a Global Respiratory Study

A leading global biopharmaceutical company urgently requested CSI to supply the Fluarix QIV Southern Hemisphere Vaccine for 2025.

Rapid Sourcing of Discontinued Southern Hemisphere Vaccine for a Global Biopharmaceutical Client

Securing reliable, cost-effective, long-term supply of Eylea PFS from EU and USA for a global biotech company’s clinical studies.

Securing Long-Term, Cost-Effective Supply of Eylea EU & USA for programs of studies

A biotech client asked CSI to source Lucentis for a Phase II ophthalmology trial.

Comparator Sourcing for a Phase II Ophthalmology Study

CSI Efficiently Delivered Venetoclax and Azacitidine Across 17 Countries

How CSI streamlined Venetoclax and Azacitidine supply across 17 countries in record time

Export of expensive comparators from Europe to China with first leg documents and streamlined approach

CSI’s seamless comparator export to China

CSI’s flexible approach to global distribution ensured a large CRO's five-year and three-year studies across a total of 18 countries could proceed without delay

Global Device Distribution

How CSI fulfilled what our competitors couldn’t: rapidly sourcing oncology medication from the EU for a trial in South Korea

Rescuing a Biotech’s Oncology Trial with Lenvima

How CSI has saved a leading global pharmaceutical company €1 million by sourcing pembrolizumab from the market at the best possible price

Delivering €1 million Savings for Pembrolizumab

How CSI supplied large quantities of Jakavi to a Biotech’s ongoing Phase 3 oncology study involving 14 countries, nine depots and 67 site shipments

Global Jakavi Study

Challenge

A listed global Biotech approached CSI with the challenge of sourcing cetuximab with Certificate of Analysis (CoA) in Belgium, France, Italy, Spain and Czech Republic for a European oncology trial. The product in question was scarce on the market at the time and the client had recently been let down by a competitor, so supply timelines were extremely tight – the first shipment was required in less than 8 weeks. To make matters more complex, a quota system had been introduced for the product in some markets, with suppliers receiving only a small quantity of the product as stock was needed to supply the local market.

Solution

CSI proved flexible in offering to start the work of sourcing and purchasing the product following receipt of email confirmation of the award of the study – before the client had even finalised the full scope of work and raised a purchase order – in order to condense timelines. We were then able to leverage our European supplier contacts to source the product very quickly and, within six days of the client’s original request, CSI had formed a comprehensive proposal for the client, including all costs for sourcing and distribution.

Result

The Biotech was able to proceed with their oncology study in Europe without delay to its timelines. CSI received glowing feedback from the client for its work in supporting this trial and has since been awarded further business from them.

Case Study

Rescuing a Global Biotech's Oncology Study with Cetuximab

How CSI rescued an oncology trial when a competitor failed to deliver, despite an extremely tight deadline and scarce supply on the market

Challenge

To source cetuximab with CoA in several European countries to rescue an oncology trial for a Biotech who had been let down by a competitor

Solution

CSI proved its agility and flexibility, leveraging its supplier relationships and sourcing the product within six days of the client’s request

Result

The Biotech was able to proceed with their oncology study without delay and CSI has since been awarded further business from them

Contact us 

Get in touch with a member of our experienced team today to discuss your clinical trial supply requirements

bottom of page